Security key
589492107
Mereo BioPharma Group plc - Ordinary Shares (MREO)
CUSIP: 589492107
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Ordinary Shares
- Shares outstanding
- 795,765,179
- Total 13F shares
- 89,643,356
- Share change
- -596,546
- Total reported value
- $284,079,000
- Put/Call ratio
- 68%
- Price per share
- $3.17
- Number of holders
- 68
- Value change
- -$2,186,471
- Number of buys
- 36
- Number of sells
- 25
Report period
Q2 2021
Institutions
68
Top holders
10
MREO full security history
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Mereo BioPharma Group plc SEC filings
Mereo BioPharma Group plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 589492107
Recent filing periods:
Top shareholders of MREO - Mereo BioPharma Group plc - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. |
13F
|
Company |
1%
|
8,276,500
|
$27,892,000 | — | 31 Mar 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.84%
|
6,719,948
|
$22,646,000 | — | 31 Mar 2021 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.8%
|
6,365,500
|
$21,452,000 | — | 31 Mar 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
0.78%
|
6,226,673
|
$20,984,000 | — | 31 Mar 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.75%
|
6,000,000
|
$20,220,000 | — | 31 Mar 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.56%
|
4,494,869
|
$15,148,000 | — | 31 Mar 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
0.53%
|
4,220,938
|
$14,225,000 | — | 31 Mar 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.37%
|
2,976,121
|
$10,030,000 | — | 31 Mar 2021 | |
| Rubric Capital Management LP |
13F
|
Company |
0.37%
|
2,914,861
|
$9,823,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.33%
|
2,589,367
|
$8,726,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.31%
|
2,437,258
|
$8,213,000 | — | 31 Mar 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.26%
|
2,048,757
|
$6,904,000 | — | 31 Mar 2021 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.24%
|
1,935,600
|
$6,523,000 | — | 31 Mar 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.19%
|
1,500,000
|
$5,055,000 | — | 31 Mar 2021 | |
| Endurant Capital Management LP |
13F
|
Company |
0.17%
|
1,339,835
|
$4,515,000 | — | 31 Mar 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.16%
|
1,312,415
|
$4,423,000 | — | 31 Mar 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.16%
|
1,273,053
|
$4,291,000 | — | 31 Mar 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.16%
|
1,250,000
|
$4,213,000 | — | 31 Mar 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.16%
|
1,249,648
|
$4,211,000 | — | 31 Mar 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.14%
|
1,146,308
|
$419,000 | — | 31 Mar 2021 | |
| Holocene Advisors, LP |
13F
|
Company |
0.14%
|
1,129,987
|
$3,808,000 | — | 31 Mar 2021 | |
| Asymmetry Capital Management, L.P. |
13F
|
Company |
0.13%
|
1,063,264
|
$3,583,000 | — | 31 Mar 2021 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.13%
|
1,000,000
|
$3,370,000 | — | 31 Mar 2021 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.13%
|
997,290
|
$3,361,000 | — | 31 Mar 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.11%
|
900,000
|
$3,033,000 | — | 31 Mar 2021 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.06%
|
489,100
|
$1,648,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
267,200
|
$900,000 | — | 31 Mar 2021 | |
| Delphi Management Partners VIII, L.L.C. |
13F
|
Company |
0.03%
|
256,734
|
$865,000 | — | 31 Mar 2021 | |
| Insight Advisors, LLC/ PA |
13F
|
Company |
0.03%
|
228,725
|
$812,000 | — | 31 Mar 2021 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
175,000
|
$590,000 | — | 31 Mar 2021 | |
| HealthCor Management, L.P. |
13F
|
Company |
0.02%
|
149,170
|
$503,000 | — | 31 Mar 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
148,048
|
$499,000 | — | 31 Mar 2021 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
143,967
|
$485,000 | — | 31 Mar 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.01%
|
100,514
|
$339,000 | — | 31 Mar 2021 | |
| Creative Planning |
13F
|
Company |
0.01%
|
79,169
|
$267,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
78,988
|
$266,000 | — | 31 Mar 2021 | |
| PERSONAL CFO SOLUTIONS, LLC |
13F
|
Company |
0.01%
|
74,776
|
$252,000 | — | 31 Mar 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.01%
|
73,558
|
$248,000 | — | 31 Mar 2021 | |
| Atom Investors LP |
13F
|
Company |
0.01%
|
65,924
|
$222,000 | — | 31 Mar 2021 | |
| J. Goldman & Co LP |
13F
|
Company |
0.01%
|
62,767
|
$212,000 | — | 31 Mar 2021 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.01%
|
58,217
|
$196,000 | — | 31 Mar 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
47,219
|
$159,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
44,071
|
$149,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
32,987
|
$111,000 | — | 31 Mar 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0%
|
17,699
|
$60,000 | — | 31 Mar 2021 | |
| Shay Capital LLC |
13F
|
Company |
0%
|
17,267
|
$58,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0%
|
15,954
|
$54,000 | — | 31 Mar 2021 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0%
|
15,089
|
$51,000 | — | 31 Mar 2021 | |
| Wealthspire Advisors, LLC |
13F
|
Company |
0%
|
14,276
|
$48,000 | — | 31 Mar 2021 | |
| Cetera Investment Advisers |
13F
|
Company |
0%
|
14,100
|
$48,000 | — | 31 Mar 2021 |
Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares (MREO) as of Q2 2021
As of 30 Jun 2021,
Mereo BioPharma Group plc - Ordinary Shares (MREO) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,643,356 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Point72 Asset Management, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, BOXER CAPITAL, LLC, Rubric Capital Management LP, Rock Springs Capital Management LP, Vivo Capital, LLC, HHLR ADVISORS, LTD., CITADEL ADVISORS LLC, and BAKER BROS. ADVISORS LP.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
64
Q2 2021 holders
68
Holder diff
4
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.